{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:49:21Z","timestamp":1776196161530,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11095-021-02985-2","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:54:36Z","timestamp":1612932876000},"page":"319-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Generation of Ophthalmic Nanosuspension of Prednisolone Acetate Using a Novel Technology"],"prefix":"10.1007","volume":"38","author":[{"given":"Yash","family":"Nandwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind Kumar","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"issue":"8","key":"2985_CR1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1185\/030079905X56538","volume":"21","author":"JL Gayton","year":"2005","unstructured":"Gayton JL. A clinical comparison of two different prednisolone acetate formulations in patients undergoing cataract surgery. Curr Med Res Opin. 2005;21(8):1291\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"1\u20132","key":"2985_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","volume":"340","author":"M Kassem","year":"2007","unstructured":"Kassem M, Rahman AA, Ghorab M, Ahmed M, Khalil R. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340(1\u20132):126\u201333.","journal-title":"Int J Pharm"},{"key":"2985_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajo.2019.10.032","volume":"211","author":"J Sheppard","year":"2020","unstructured":"Sheppard J, Garg S, Lievens C, Brandano L, Wirostko B, Korenfeld M, et al. Iontophoretic dexamethasone phosphate compared to topical prednisolone acetate 1% for noninfectious anterior segment uveitis. Am J Ophthalmol. 2020;211:76\u201386.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2985_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1021\/je101201w","volume":"56","author":"G Hu","year":"2011","unstructured":"Hu G, Cui L, Li H, Li H. Measurement and correlation of the solubility of prednisone acetate in different solvents. J Chem Eng Data. 2011;56(5):2133\u20135.","journal-title":"J Chem Eng Data"},{"issue":"2","key":"2985_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jchromb.2003.12.015","volume":"802","author":"VA Frerichs","year":"2004","unstructured":"Frerichs VA, Tornatore KM. Determination of the glucocorticoids prednisone, prednisolone, dexamethasone, and cortisol in human serum using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B. 2004;802(2):329\u201338.","journal-title":"J Chromatogr B"},{"key":"2985_CR6","unstructured":"Marlowe ZT, Davio SR. Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%). Clinical ophthalmology (Auckland, NZ). 2014;8:23."},{"issue":"2","key":"2985_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/jop.2006.0070","volume":"23","author":"CW Roberts","year":"2007","unstructured":"Roberts CW, Nelson PL. Comparative analysis of prednisolone acetate suspensions. J Ocul Pharmacol Ther. 2007;23(2):182\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"key":"2985_CR8","volume-title":"Dana R","author":"C Jumelle","year":"2020","unstructured":"Jumelle C, Gholizadeh S, Annabi N. Dana R. Journal of Controlled Release: Advances and limitations of drug delivery systems formulated as eye drops; 2020."},{"issue":"2","key":"2985_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","volume":"149","author":"HS Ali","year":"2011","unstructured":"Ali HS, York P, Ali AM, Blagden N. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 2011;149(2):175\u201381.","journal-title":"J Control Release"},{"key":"2985_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","volume":"122","author":"DR Janagam","year":"2017","unstructured":"Janagam DR, Wu L, Lowe TL. Nanoparticles for drug delivery to the anterior segment of the eye. Adv Drug Deliv Rev. 2017;122:31\u201364.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"2985_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131\u20135.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2985_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jps.2600750316","volume":"75","author":"H-W Hui","year":"1986","unstructured":"Hui H-W, Robinson JR. Effect of particle dissolution rate on ocular drug bioavailability. J Pharm Sci. 1986;75(3):280\u20137.","journal-title":"J Pharm Sci"},{"issue":"7","key":"2985_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1211\/0022357023691","volume":"56","author":"V Patravale","year":"2004","unstructured":"Patravale V, Date AA, Kulkarni R. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827\u201340.","journal-title":"J Pharm Pharmacol"},{"key":"2985_CR14","doi-asserted-by":"crossref","unstructured":"Peters MCC, Santos Neto Ed, Monteiro LM, Yukuyama MN, Machado MGM, de Oliveira IF, et al. Advances in ophthalmic preparation: the role of drug nanocrystals and lipid based nanosystems. J Drug Target 2020;28(3):259\u2013270.","DOI":"10.1080\/1061186X.2019.1663858"},{"issue":"4","key":"2985_CR15","first-page":"399","volume":"6","author":"OP Sharma","year":"2016","unstructured":"Sharma OP, Patel V, Mehta T. Nanocrystal for ocular drug delivery: hope or hype. Drug delivery and translational research. 2016;6(4):399\u2013413.","journal-title":"Drug delivery and translational research"},{"issue":"3","key":"2985_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","volume":"160","author":"L Gao","year":"2012","unstructured":"Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals: in vivo performances. J Control Release. 2012;160(3):418\u201330.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"2985_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","volume":"399","author":"R Shegokar","year":"2010","unstructured":"Shegokar R, M\u00fcller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm. 2010;399(1\u20132):129\u201339.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2985_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.03.048","volume":"467","author":"A Tuomela","year":"2014","unstructured":"Tuomela A, Liu P, Puranen J, R\u00f6nkk\u00f6 S, Laaksonen T, Kalesnykas G, et al. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo. Int J Pharm. 2014;467(1\u20132):34\u201341.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2985_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.03.029","volume":"375","author":"HS Ali","year":"2009","unstructured":"Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm. 2009;375(1\u20132):107\u201313.","journal-title":"Int J Pharm"},{"key":"2985_CR20","volume-title":"Chowhan MA","author":"EJ Castillo","year":"2010","unstructured":"Castillo EJ, Asgharian B. Chowhan MA. Google Patents: Stabilized pharmaceutical sub-micron suspensions and methods of forming same; 2010."},{"key":"2985_CR21","volume-title":"Dantuluri AKR","author":"AK Bansal","year":"2017","unstructured":"Bansal AK. Dantuluri AKR. Bapurao PY. Nanocrystalline solid dispersion compositions and process of preparation thereof. Google Patents: Bhaskarao SG; 2017."},{"key":"2985_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejps.2018.12.006","volume":"128","author":"S Sheokand","year":"2019","unstructured":"Sheokand S, Navik U, Bansal AK. Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz [a] anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats. Eur J Pharm Sci. 2019;128:240\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2985_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/10837450.2019.1669181","volume":"25","author":"S Nandi","year":"2020","unstructured":"Nandi S, Kaur A, Bansal AK. Dual drug nanocrystals loaded microparticles for fixed dose combination of simvastatin and ezetimibe. Pharm Dev Technol. 2020;25(1):40\u201353.","journal-title":"Pharm Dev Technol"},{"issue":"4","key":"2985_CR24","first-page":"392","volume":"6","author":"G Shete","year":"2016","unstructured":"Shete G, Bansal AK. NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potential. Drug delivery and translational research. 2016;6(4):392\u20138.","journal-title":"Drug delivery and translational research."},{"issue":"1","key":"2985_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijpharm.2015.08.093","volume":"495","author":"V Bhatt","year":"2015","unstructured":"Bhatt V, Shete G, Bansal AK. Mechanism of generation of drug nanocrystals in celecoxib: mannitol nanocrystalline solid dispersion. Int J Pharm. 2015;495(1):132\u20139.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2985_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0378-5173(01)00801-8","volume":"226","author":"A Forster","year":"2001","unstructured":"Forster A, Hempenstall J, Tucker I, Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm. 2001;226(1\u20132):147\u201361.","journal-title":"Int J Pharm"},{"issue":"15","key":"2985_CR27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.addr.2008.09.002","volume":"60","author":"J Jiao","year":"2008","unstructured":"Jiao J. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev. 2008;60(15):1663\u201373.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"2985_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/pharmaceutics11100516","volume":"11","author":"A Kaur","year":"2019","unstructured":"Kaur A, Parmar PK, Bansal AK. Evaluation of different techniques for size determination of drug nanocrystals: a case study of celecoxib nanocrystalline solid dispersion. Pharmaceutics. 2019;11(10):516.","journal-title":"Pharmaceutics."},{"issue":"4","key":"2985_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1293\/tox.2015-0022","volume":"28","author":"M Furukawa","year":"2015","unstructured":"Furukawa M, Sakakibara T, Itoh K, Kawamura K, Sasaki S, Matsuura M. Histopathological evaluation of the ocular-irritation potential of shampoos, make-up removers and cleansing foams in the bovine corneal opacity and permeability assay. J Toxicol Pathol. 2015;28(4):243\u20138.","journal-title":"J Toxicol Pathol"},{"issue":"2","key":"2985_CR30","first-page":"1","volume":"1","author":"A Huhtala","year":"2008","unstructured":"Huhtala A, Salminen L, T\u00e4hti H, Uusitalo H. Corneal models for the toxicity testing of drugs and drug releasing materials. Topics in multifunctional biomaterials and devices. 2008;1(2):1\u201323.","journal-title":"Topics in multifunctional biomaterials and devices"},{"issue":"1\u20132","key":"2985_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.05.023","volume":"490","author":"B McKenzie","year":"2015","unstructured":"McKenzie B, Kay G, Matthews KH, Knott RM, Cairns D. The hen\u2019s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine containing gel: quantification using Photoshop\u00ae and ImageJ. Int J Pharm. 2015;490(1\u20132):1\u20138.","journal-title":"Int J Pharm"},{"issue":"2","key":"2985_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/jop.1991.7.175","volume":"7","author":"D Musson","year":"1991","unstructured":"Musson D, Bidgood A, Olejnik O. Comparative corneal penetration of prednisolone sodium phosphate and prednisolone acetate in NZW rabbits. J Ocul Pharmacol Ther. 1991;7(2):175\u201382.","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-02985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-021-02985-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-02985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T16:47:28Z","timestamp":1614617248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-021-02985-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2985"],"URL":"https:\/\/doi.org\/10.1007\/s11095-021-02985-2","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}